1. Diabet si rezistentei insulinice: Richard A. Anderson, Ph.D., by 1998 “In toate studiile cu biodisponibilitatea cromului picolinat sau raportat efecte pozitive"
2. Cardiovascular April 2002: “La bolile cardiovasculare se poate spune sint cauze de deficienta de crom in alimentatie.” Suplementarea de Crom ajuta la reducerea bolilor cardiovasculare si a complicatiilor acestora
3. “O inbunatatire de 3% de Crom in nivelul seric de colesterol poate reduce 15% incidente de boli cardiovasculare in paralel are efect de a reduce valorile ale lipoproteinelor cu densitate joasa (colesterolul-LDL-rau) si a creste concentratia plasmatica a lipoproteinelor cu densitate inalta (colesterolul-HDL-bun) poate reduce 2-3% bolile cardiovasculare.”
4. “Obezitate 28 de studii
din 1971 cu suplimentare de Crom la reducerea de colesrolului seric si a metabolizmului
lipidic.
In studiile randomizate, dublu-orb, placebo controlat au aratat la o dieta
sanatoasa si exercitiu fizic cromul poate reduce tesutul adipos si adaos de
masa musculara la persoane dieta de calorii foarte reduse (1977). Suplemntele
nutritive cu Crom sint sigure si efective de a reduce greutatea corporala.”
5. “La depresie studiile au aratat ca suplementarea de Crom au un rol important in functiile biochemice si metabolice.”
“Studiile University of North Carolina’s Dr. Malcolm McLeod, Duke University’s Dr. Jonathan Davidson au gasit prin suplementarea de Crom la 15 persoane cu depresie atipica sa constatat o inbunatatire a oboselii, depresiei si la 60% simptomele au fost eliminate.”
“Alte studii din 1999, 2000 si 2002 au contribuit la intelegerea cromului picolinat in conectiunile de neurotransmiteri cu metabolizmul insulinic.”
| Bibliografie-Referinte: |
|
1. Richard A. Anderson, Ph.D., by 1998 “Essentially all of the studies employing the more bio-available chromium picolinate have reported positive effects, while there have been varying effects when other forms of chromium have been used,” wrote Anderson.
2. Cardiovascular. According to an April 2002 scientific presentation,“Functional chromium deficiency in people with cardiovascular disease may be directly related to a relative lack of chromium in the diet.”Chromium supplementation helps in reducing the risk of early onset of coronary heart disease by reducing the associated risk of complications.
3. “Chromium’s average improvement in total cholesterol levels (3 percent) can provide a 15 percent reduction in the incidence of coronary heart disease (CHD); a parallel decrease in LDL (or “bad”) cholesterol and an increase in HDL (or “good”) cholesterol can reduce the risk of CHD by two to three percent.”
4. “Obesity. At least 28 studies since 1971 have looked at chromium supplementation in reference to cholesterol and lipid metabolism. Double-blind, placebo-controlled studies have demonstrated that, as part of a healthy diet and exercise program, chromium supplementation can help reduce body fat, increase or maintain lean body tissue (i.e., muscle) and can lead to weight loss. Chromium picolinate supplementation led to increased lean body mass in obese patients on very-low-calorie-diets (1997), Clearly, any safe, effective nutritional compound that can help people lose weight while retaining lean muscle mass in the context of diets that are not severely calorie-restrictive, is a compound worth considering—chromium picolinate is such a compound.”
5. “Depression. A number of recent studies have uncovered key insights into the beneficial role chromium picolinate supplementation plays in the metabolic and biochemical pathways of depressive illness.”
“Building on pioneering research by the University of North Carolina’s Dr. Malcolm McLeod, Duke University’s Dr. Jonathan Davidson recently published his findings in which chromium supplementation in 15 patients with atypical depression yielded significant improvement in such behaviors and symptoms as overeating, hostility/interpersonal sensitivity, fatigue, depression. In fact, chromium picolinate supplementation brought on a 60 percent rate for full remission of symptoms.”
“Other studies. in 2002, 2000 and 1999 contributed to the groundwork for what is becoming a new understanding of chromium picolinate’s role in brain neurotransmission and its connection with insulin metabolism.”